Ragosa Mark bought KNSA
November 2, 2026 · Form 4 insider transaction
Ragosa Mark bought 9,636 shares of Kiniksa Pharmaceuticals International, plc at $10.76 per share, a transaction worth $103.7K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
9,636
Price
$10.76
Total value
$103.7K
InsiderRagosa Mark
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeM: Option exercise
Transaction dateNovember 2, 2026
Filing dateNovember 3, 2026
Shares owned after30,490
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 29, 2026.